Yildiz, YesimOzger, Hasan SelcukAcar, AliSeremet-Keskin, AysegulBinay, Umut DevrimUnlu, GultenBayram, Halim2024-08-042024-08-0420232667-646Xhttps://doi.org/10.36519/idcm.2023.216https://search.trdizin.gov.tr/yayin/detay/1183916https://hdl.handle.net/11616/92932Objective: We aimed to investigate the vaccination status and the risk factors for the intensive care unit (ICU) support need of the laboratory-confirmed breakthrough COVID-19 infection inpatients. Materials and Methods: This multi-center point-prevalence study was conducted on inpatients, divided into two groups as 'fully' and 'partially' vaccinated according to COVID-19 vaccination status. Results: Totally 516 patients were included in the study. The median age was 65 (55-77), and 53.5% (n=276) of the patients were male. Hypertension (41.9%, n=216), diabetes mellitus (DM) (31.8%, n=164), and coronary artery disease (CAD) (16.3%, n=84) were the predominant comorbidities. Patients were divided into two groups ICU (n=196) and non-ICU (n=301). Hypertension (p=0.026), DM (p=0.048), and congestive heart failure (CHF) (p=0.005) were significantly higher in ICU patients and the median age was younger among non-ICU patients (p=0.033). Of patients, 16.9% (n=87) were fully vaccinated, and this group's need for ICU support was statistically significantly lower (p=0.021). Conclusion: We conclude that older age, hypertension, DM, CHF, and being partially vaccinated were associated with the need for ICU support. Therefore, all countries should continuously monitor post-vaccination breakthrough COVID-19 infections to determine the national booster vaccine administration approach that will provide vulnerable individuals the highest protection.eninfo:eu-repo/semantics/openAccessCOVID-19 vaccineintensive care unitrisk factorSARS-CoV-2 infectionvaccine breakthrough infectionsvariant of concernsArticle521181263863301110.36519/idcm.2023.2161183916WOS:001138794000007Q4